New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...

Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal ...

KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...

Although the gut renews itself constantly, its stem cells accumulate age-related molecular changes that quietly alter how ...

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...

The family thought they had finally cracked the impossible puzzle of modern parenting: a trusted grandma watching the kids so ...

Genentech's PD-L1 inhibitor combined with Avastin and chemo improved median progression-free survival by around 20 months ...

FIT checks for blood in the stool, which can indicate the presence of colorectal cancer or polyps. Patients collect stool ...

Colorectal cancer cases are rising among people under 50. While cancer can happen to anyone — and the cause is often unknown ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

Guardant Health's Shield blood test for colorectal cancer screening is now covered by TRICARE, providing active duty service ...